<DOC>
	<DOCNO>NCT02525055</DOCNO>
	<brief_summary>The investigator conduct initial safety characterisation study healthy adult volunteer , utilise unique clinical quarantine facility London , UK .</brief_summary>
	<brief_title>The Manufacture New Wild-Type H3N2 Virus Human Viral Challenge Model</brief_title>
	<detailed_description>Influenza associate disease major cause morbidity mortality . The United States Advisory Committee Immunization Practices recommend influenza vaccination everyone 6 month age The failure flu vaccine 2014-2015 [ demonstrates need model allow rapid development novel antiviral , universal/intra-seasonal vaccine , immunomodulators , monoclonal antibody novel treatment . To end manufactured new H3N2 influenza virus compliance Good Manufacturing Practice use Human Viral Challenge Model . The investigator choose H3N2 influenza subtype , rather H1N1 , give strain substantial impact term morbidity mortality annually describe Centre Disease Control . The investigator first subject virus batch rigorous adventitious agent test , confirm virus wild-type Sanger sequencing determine virus titre appropriate human use via establish ferret model . We build previous experience H3N2 H1N1 viruses develop unique model . Investigators conduct initial safety characterisation study healthy adult volunteer , utilise unique clinical quarantine facility London , UK .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Young healthy adult determine medical history , physical examination , serology ( HIV Hepatitis B C ) clinical laboratory test . Female subject require provide history reliable contraceptive practice . include ; asthma , hypersensitivity mercurials chicken egg , anatomic neurologic abnormality impair gag reflex contribute aspiration , * chronic nasopharyngeal complaint , abnormal electrocardiogram ( ECG ) , febrile illness significant symptom upper respiratory infection day Subjects use medication product rhinitis nasal congestion , Subject receive systemic glucocorticoid within 1 month , cytotoxic immunosuppressive drug within 6 month study start . Subjects agree smoke quarantine phase .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Flu</keyword>
	<keyword>Influenza</keyword>
	<keyword>Human Viral Challenge Model</keyword>
	<keyword>Wild-Type</keyword>
	<keyword>H3N2</keyword>
	<keyword>H1N1</keyword>
	<keyword>Universal Influenza Vaccine</keyword>
	<keyword>intra-seasonal vaccine</keyword>
	<keyword>antiviral</keyword>
</DOC>